Emergent Biosolutions Inc
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intrav… Read more
Emergent Biosolutions Inc (EBS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.149x
Based on the latest financial reports, Emergent Biosolutions Inc (EBS) has a cash flow conversion efficiency ratio of 0.149x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($77.70 Million) by net assets ($522.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Emergent Biosolutions Inc - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Emergent Biosolutions Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Emergent Biosolutions Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Emergent Biosolutions Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rural Funds Group
PINK:RFNDF
|
0.028x |
|
Huishang Bank Corporation Limited
PINK:HHSSF
|
N/A |
|
Ontex Group NV
PINK:ONXXF
|
0.072x |
|
mixi Inc
F:MXN
|
0.056x |
|
Havas N.V.
F:JP71
|
N/A |
|
AB S.A. ZY 1
F:8B6
|
N/A |
|
Anhui Ronds Science & Technology Inc Co
SHG:688768
|
-0.654x |
|
Ningbo Sunrise Elc Technology Co Ltd Class A
SHE:002937
|
0.021x |
Annual Cash Flow Conversion Efficiency for Emergent Biosolutions Inc (2004–2025)
The table below shows the annual cash flow conversion efficiency of Emergent Biosolutions Inc from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $522.60 Million | $170.60 Million | 0.326x | +168.50% |
| 2024-12-31 | $482.80 Million | $58.70 Million | 0.122x | +138.27% |
| 2023-12-31 | $649.30 Million | $-206.30 Million | -0.318x | -1188.61% |
| 2022-12-31 | $1.38 Billion | $-34.10 Million | -0.025x | -112.37% |
| 2021-12-31 | $1.61 Billion | $321.10 Million | 0.199x | -46.30% |
| 2020-12-31 | $1.45 Billion | $536.90 Million | 0.371x | +114.83% |
| 2019-12-31 | $1.09 Billion | $188.00 Million | 0.173x | +317.70% |
| 2018-12-31 | $1.01 Billion | $41.80 Million | 0.041x | -81.88% |
| 2017-12-31 | $912.35 Million | $208.14 Million | 0.228x | +154.30% |
| 2016-12-31 | $596.21 Million | $53.49 Million | 0.090x | +33.18% |
| 2015-12-31 | $660.02 Million | $44.46 Million | 0.067x | -66.82% |
| 2014-12-31 | $553.20 Million | $112.32 Million | 0.203x | +2.42% |
| 2013-12-31 | $489.17 Million | $96.97 Million | 0.198x | +121.08% |
| 2012-12-31 | $442.13 Million | $39.64 Million | 0.090x | +156.05% |
| 2011-12-31 | $416.73 Million | $14.59 Million | 0.035x | -86.86% |
| 2010-12-31 | $373.56 Million | $99.54 Million | 0.266x | +112.94% |
| 2009-12-31 | $243.81 Million | $30.51 Million | 0.125x | +240.94% |
| 2008-12-31 | $199.35 Million | $7.32 Million | 0.037x | -88.67% |
| 2007-12-31 | $171.16 Million | $55.45 Million | 0.324x | +1204.61% |
| 2006-12-31 | $138.47 Million | $-4.06 Million | -0.029x | -104.15% |
| 2005-12-31 | $59.74 Million | $42.25 Million | 0.707x | +76.50% |
| 2004-12-31 | $22.95 Million | $9.20 Million | 0.401x | -- |